ASO Author Reflections: Beyond Neoadjuvant Therapy in Pancreatic Cancer—Why Adjuvant Therapy Still Matters After Neoadjuvant Treatment
Crossref DOI link: https://doi.org/10.1245/s10434-026-19965-8
Published Online: 2026-06-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Frey, Michael C.
Eshmuminov, Dilmurodjon
Text and Data Mining valid from 2026-06-06
Version of Record valid from 2026-06-06
Article History
Received: 22 May 2026
Accepted: 23 May 2026
First Online: 6 June 2026
Disclosure
: The authors declare no conflicts of interest.